Efficacy of two endectoparasiticide products combining fipronil and (S)-methoprene or esafoxolaner with eprinomectin and praziquantel against fleas and intestinal helminths in cats naturally infested in Brazil.

Eprinomectin and praziquantel, nematodicide and cestodicide compounds, are both combined with the insecticide and acaricide compounds fipronil and (S)-methoprene in Frontline® Protect/Broadline®, or esafoxolaner in NexGard® Combo. These topical feline endectoparasiticide products were tested for efficacy against fleas and intestinal helminths in a field trial in Brazil. Flea- and/or helminth-infested domestic cats were treated twice at a monthly interval following label instructions: 160 cats with Frontline® Protect/Broadline® and 165 cats with NexGard® Combo. The flea and intestinal helminth infestations were evaluated using comb counts and copromicroscopy, respectively before first treatment for baseline value, then 9 and 30 days after each treatment for fleas, and 9 days after each treatment for helminths. Multiparasitism was very frequent at baseline, as amongst the 325 included cats, 295, 280, 86 and 93 cats were at least infested with Ctenocephalides fleas, Ancylostoma, Toxocara and Dipylidium caninum, respectively. Efficacies were calculated by comparing the geometric means at baseline and at post-treatment timepoints for each parasite genus/species. Inclusive of both products and of all evaluation timepoints, the Ctenocephalides, Ancylostoma, Toxocara and D. caninum efficacies were at least 98.3%, 99.8%, 99.8% and 96.3%, respectively. No adverse reactions were observed, except for a few instances of mild, transient, and self-resolving hypersalivation occurring on the day of treatment in both groups. This field trial demonstrated high-level efficacy of Frontline® Protect/Broadline® and NexGard® Combo against major parasites of cats in Brazil.

TITLE: Efficacité de deux produits endectoparasiticides associant fipronil et (S)-méthoprène ou esafoxolaner à l'éprinomectine et au praziquantel contre les puces et les helminthes intestinaux chez les chats naturellement infestés au Brésil. ABSTRACT: L'éprinomectine et le praziquantel, composés nématodicides et cestodicides, sont tous les deux associés aux composés insecticides et acaricides fipronil et (S)-méthoprène dans Frontline® Protect/Broadline®, ou esafoxolaner dans NexGard® Combo. Ces produits endectoparasiticides félins topiques ont été testés pour leur efficacité contre les puces et les helminthes intestinaux lors d'un essai sur le terrain au Brésil. Des chats domestiques infestés de puces et/ou d'helminthes ont été traités deux fois à intervalle d'un mois en suivant les instructions d'utilisation, 160 chats avec Frontline® Protect/Broadline® et 165 chats avec NexGard® Combo. Les infestations par les puces et les helminthes intestinaux ont été évaluées en utilisant respectivement par comptage au peigne et par copromicroscopie, avant le premier traitement pour la valeur de base, puis 9 et 30 jours après chaque traitement pour les puces, et 9 jours après chaque traitement pour les helminthes. Le multiparasitisme était très fréquent à l'inclusion puisque parmi les 325 chats inclus, 295, 280, 86 et 93 chats étaient au moins infestés respectivement par les puces Ctenocephalides, ou Ancylostoma, Toxocara et Dipylidium caninum. Les efficacités ont été calculées en comparant les moyennes géométriques au départ et aux points d'évaluation post-traitement pour chaque genre/espèce de parasite. En incluant les deux produits et tous les points temporels d'évaluation, les efficacités contre Ctenocephalides, Ancylostoma, Toxocara et D. caninum étaient respectivement d'au moins 98,3 %, 99,8 %, 99,8 % et 96,3 %. Aucun effet indésirable n'a été observé à l'exception de quelques cas d'hypersalivation légère, transitoire et auto-résolvante survenant le jour d'un traitement dans les deux groupes. Cet essai sur le terrain a démontré une efficacité de haut niveau de Frontline® Protect / Broadline® et NexGard® Combo contre les principaux parasites des chats au Brésil.

Epidemiological investigation of Borrelia burgdorferi in horses in the municipality of Sinop-MT, Brazil.

Borrelia burgdorferi sensu stricto is the main etiological agent of Lyme disease (LD) in the USA. In Brazil, it is believed that a similar spirochete is the causal agent of the Baggio-Yoshinari syndrome (BYS), a zoonosis also transmitted by ticks, whose clinical manifestations are similar to those of LD. Despite the epidemiological importance, there are no studies reporting the presence and the prevalence of B. burgdorferi among horses in Mato Grosso State. The aim of this study was to detect and measure the frequency of IgG antibodies anti-B. burgdorferi American strain G39/40 in horses in the municipality of Sinop, MT-Brazil, using the indirect enzyme-linked immunosorbent assay (ELISA) for serological diagnosis. Blood samples from 367 horses were collected in 81 farms. An epidemiological questionnaire was applied during the visits to obtain information related to the animals and the farms. From the 367 horses, 214 were positive for B. burgdorferi sensu stricto according to the results of the ELISA test, representing an apparent prevalence of 54.04% [CI = 0.4548051-0.6237234]. Concomitantly, 89 blood samples were taken for molecular analysis by nested polymerase chain reaction (PCR). According to the PCR test results, none of the samples were reactive, although 53 of these samples were reactive according to ELISA. Seventy five farms (92.59%) had at least one reactive horse for B. burgdorferi. Our results support the hypothesis of the presence of anti-Borrelia spp. antibodies in horses in Mato Grosso, reaching a high animal prevalence. Besides that, leisure/sport purposes proved to be a risk factor, with an odds ratio of 3.16. These findings clearly indicate the need of borreliosis control in Sinop and make a significant contribution to the knowledge of the disease in Mato Grosso.